The use of lytic mycobacteriophages to treat tuberculosis under conditions of acquired resistance to anti-tuberculosis drugs is one of the most practical ways to improve the effectiveness of therapy and reduce the spread of this disease. We studied the efficacy of antimycobacterial action of mycobacteriophage D29 encapsulated into 400-nm liposomes in cell models of tuberculosis infection in vitro. The antimycobacterial action of lytic mycobacteriophage D29 used in free or liposome-encapsulated forms was demonstrated on cell models of intracellularly infected RAW264.7 macrophages and tuberculous granuloma formed by human blood mononuclear cells. The experiments demonstrated pronounced advantage of liposomal form of mycobacteriophage according to the criteria of their penetration into macrophages and lysis of Mycobacterium tuberculosis in culture.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lapenkova MB, Smirnova NS, Rutkevich PN, Vladimirsky MA. Evaluation of the Efficiency of Lytic Mycobacteriophage D29 on the Model of M. tuberculosis-Infected Macrophage RAW 264 Cell Line. Bull. Exp. Biol. Med. 2018; 164(3):344-346. doi: https://doi.org/10.1007/s10517-018-3986-0
Adriaenssens EM, Lehman SM, Vandersteegen K, Vandenheuvel D, Philippe DL, Cornelissen A, Clokie MR, García AJ, De Proft M, Maes M, Lavigne R. CIM(®) monolithic anion-exchange chromatography as a useful alternative to CsCl gradient purification of bacteriophage particles. Virology. 2012 Dec 20;434(2):265-70. doi: https://doi.org/10.1016/j.virol.2012.09.018
Cebriá-Mendoza M, Sanjuán R, Domingo-Calap P. Directed Evolution of a Mycobacteriophage. Antibiotics (Basel). 2019;8(2). pii: E46. doi: https://doi.org/10.3390/antibiotics8020046
Hatfull GF. Mycobacteriophages: windows into tuberculosis. PLoS Pathog. 2014;10(3). e1003953. doi: https://doi.org/10.1371/journal.ppat.1003953
Kiran D, Podell BK, Chambers M, Basaraba RJ. Host-directed therapy targeting the Mycobacterium tuberculous granuloma: a review. Semin. Immunopathol. 2016;38(2):167-83. doi: https://doi.org/10.1007/s00281-015-0537-x
Lin DM, Koskella B, Lin HC. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J. Gastrointest. Pharmacol. Ther. 2017;8(3):162-173. doi: https://doi.org/10.4292/wjgpt.v8.i3.162
Nieth A, Verseux C, Barnert S, Süss R, Römer W. A first step toward liposome-mediated intracellular bacteriophage therapy. Expert Opin. Drug Deliv. 2015;12(9):1411-1424. doi: https://doi.org/10.1517/17425247.2015.1043125
Nilsson AS. Phage therapy--constraints and possibilities. Ups. J. Med. Sci. 2014;119(2):192-198. doi: https://doi.org/10.3109/03009734.2014.902878
Nisini R, Poerio N, Mariotti S, De Santis F, Fraziano M. The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases. Front. Immunol. 2018;9:155. doi: https://doi.org/10.3389/fimmu.2018.00155
Singla S, Harjai K, Katare OP, Chhibber S. Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies. PLoS One. 2016;11(4). e0153777. doi: https://doi.org/10.1371/journal.pone.0153777
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 169, No. 3, pp. 334-337, March, 2020
Rights and permissions
About this article
Cite this article
Lapenkova, M.B., Alyapkina, Y.S. & Vladimirsky, M.A. Bactericidal Activity of Liposomal Form of Lytic Mycobacteriophage D29 in Cell Models of Tuberculosis Infection In Vitro. Bull Exp Biol Med 169, 361–364 (2020). https://doi.org/10.1007/s10517-020-04887-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-020-04887-6